ВПЛИВ ПРОБІОТИКІВ НА ОСНОВІ LACTOBACILLUS ТА BIFIDOBACTERIUM НА СИМПТОМИ ДЕПРЕСІЇ ТА ТРИВОГИ
Ключові слова:
microbiota-gut-brain axis, mental health, probioticsАнотація
This article is devoted to evaluate the strain-specific effects of probiotics on relieving depressive and anxiety symptoms due to the microbiota-gut-brain axis (MGBA). Probiotic supplementation targeting the MGBA offer potential benefits for managing depression and anxiety. However, more clinical studies are necessary to fully understand and the therapeutic potential of the MGBA in neurological health and disease.
Посилання
Всесвітня організація охорони здоров’я. World Health Organization (WHO). URL: https://www.who.int/ukraine/uk/publications/9789241516822 (дата звернення: 15.04.2025).
Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application / S. Ashique et al. Heliyon. Vol. 10, no. 13, 2024. URL: https://doi.org/10.1016/j.heliyon.2024.e34092.
Effect of probiotics on psychiatric symptoms and central nervous system functions in human health and disease: A systematic review and meta-analysis / C. Le Morvan de Sequeira et al. Nutrients. 2022. Vol. 14, no. 3. P. 621. URL: https://doi.org/10.3390/nu14030621.
Exploring the role and potential of probiotics in the field of mental health: major depressive disorder / D. Johnson et al. Nutrients. 2021. Vol. 13, no. 5, 1728. URL: https://doi.org/10.3390/nu13051728.
“Gut–brain axis”: Review of the role of the probiotics in anxiety and depressive disorders / E. Gambaro et al. 2022. Vol. 10, no. 10. e01803. URL: https://doi.org/10.1002/brb3.1803.
Strain-specific effects of probiotics on depression and anxiety: a meta-analysis / M. Rahmannia et al. Gut Pathog. 2024. Vol. 16, no. 46. URL: https://doi.org/10.1186/s13099-024-00634-8.